Promino Nutritional Sciences Inc.
MUSLF
$0.02
$0.00-12.31%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 583.23% | 199.21% | 11.06% | -46.66% | -9.01% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 583.23% | 199.21% | 11.06% | -46.66% | -9.01% |
| Cost of Revenue | 55.32% | -39.78% | -60.03% | -68.74% | -66.02% |
| Gross Profit | 119.56% | 91.73% | 81.67% | 76.35% | 71.86% |
| SG&A Expenses | -87.15% | -70.52% | -29.05% | 62.79% | 209.20% |
| Depreciation & Amortization | -- | -- | -- | -- | -76.92% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -75.52% | -64.27% | -35.02% | 23.58% | 87.54% |
| Operating Income | 88.83% | 72.85% | 37.55% | -29.50% | -91.64% |
| Income Before Tax | 87.69% | 63.77% | 38.29% | -27.44% | -72.11% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 87.69% | 63.77% | 38.29% | -27.44% | -72.11% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 87.69% | 63.77% | 38.29% | -27.44% | -72.11% |
| EBIT | 88.83% | 72.85% | 37.55% | -29.50% | -91.64% |
| EBITDA | 104.83% | 87.23% | 45.70% | -29.63% | -92.08% |
| EPS Basic | 94.89% | 84.08% | 64.90% | 23.20% | -28.76% |
| Normalized Basic EPS | 92.37% | 84.83% | 66.97% | 29.45% | -37.71% |
| EPS Diluted | 94.93% | 83.24% | 63.99% | 22.12% | -29.75% |
| Normalized Diluted EPS | 92.37% | 84.83% | 66.97% | 29.45% | -37.71% |
| Average Basic Shares Outstanding | 94.78% | 70.91% | 60.81% | 46.40% | 12.93% |
| Average Diluted Shares Outstanding | 94.78% | 70.91% | 60.81% | 46.40% | 12.93% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |